Upcoming Event
In-Person
HIV
24th European Meeting on HIV & Hepatitis 2026
10 – 12 June 2026
JS
Jonathan Schapiro
MD
National Hemophilia Center, Sheba Medical Center, Israel
Biography
Jonathan M Schapiro, MD has devoted his career to HIV clinical care, research and education since completing his Fellowship in Infectious Diseases and Geographic Medicine at the Stanford University School of Medicine Center For AIDS Research, Stanford CA. Dr. Schapiro Graduated from the Ben Gurion University School of Medicine and completed his Medicine Residency at the Rabin Medical Center in Israel.
Dr. Schapiro’s research has focused on the causes of antiretroviral drug failure, interventions to optimize clinical care, and new drug development. His interests have include resistance and cross-resistance between drugs, associations between resistance and pharmacology, development of new antiretroviral agents with improved resistance and pharmacological profiles, the clinical utility of resistance and drug level testing, and integrating resistance assays and other diagnostics into clinical care. He has been involved in the development of advanced interpretation systems for these assays, and has worked to highlight the importance of interactions between drug exposure and resistance. Dr. Schapiro currently runs the HIV/AIDS clinic at the National Hemophilia Center in Tel Aviv, Israel.
LATEST RELATED PROGRAMS
RELATED MATERIALS
RELATED COURSES
HIV
HIV
60 min
Romain Palich, Jose Arribas, Laura Waters, Borja Mora-Peris, Jonathan Schapiro
HIV 24/7 | Practical Considerations for Long-Acting Antiretroviral Therapy
The HIV 24/7 series is an educational resource that provides clear and concise education on HIV care for healthcare professionals who occasionally treat individuals living with HIV. All modules can be followed independently and at your own pace. Complete this entire module to equip yourself with the knowledge to address the specific challenges in your care and treatment of people living with HIV.
What Will Set You Apart?
After following this educational series, participants will:
- Be able to provide guidance on choosing anti-retroviral therapy regimens which are best suited to the individual needs of PLWHIV.
- Be informed of the new data on available ARVs for both drug naïve and drug-experienced patients.
- Be able to identify key characteristics of individuals that will allow optimal use of the many available PrEP and treatment options.
Is This Program for You?
The program is aimed at clinicians from various specialties who occasionally treat people who live with HIV, such as primary care physicians, family doctors, OBGYN, HIV care nurses, transgender healthcare clinicians, adolescent medicine professionals, and preventive medicine professionals, as well as public health workers and researchers engaged in HIV-related disciplines at varying degrees.
What Will You Cover in This Module?
- Checklist for Clinicians for Optimal Initiation of Long-Acting IM Therapy
- Key Topics to Discuss with Your Patient before Starting Long-Acting Therapy
- Practical Steps in Organizing your Clinic for Long-Acting IM Therapy
- Tips to Minimize Injection Site Reactions
Program Director: Jonathan Schapiro
HIV
HIV
60 min
Laura Waters, Jonathan Schapiro
HIV 24/7 | Clinical Considerations for Long-Acting Antiretroviral Therapy
The HIV 24/7 series is an educational resource that provides clear and concise education on HIV care for healthcare professionals who occasionally treat individuals living with HIV.
Complete this entire module to equip yourself with the knowledge to address the specific challenges in your care and treatment of people living with HIV. All modules can be followed independently and at your own pace.
What Will Set You Apart?
After following this educational series, participants will:
- Be able to provide guidance on choosing anti-retroviral therapy regimens which are best suited to the individual needs of PLWHIV.
- Be informed of the new data on available ARVs for both drug naïve and drug-experienced patients.
- Be able to identify key characteristics of individuals that will allow optimal use of the many available PrEP and treatment options.
Is This Program for You?
The program is aimed at clinicians from various specialties who occasionally treat people who live with HIV, such as primary care physicians, family doctors, OBGYN, HIV care nurses, transgender healthcare clinicians, adolescent medicine professionals, and preventive medicine professionals, as well as public health workers and researchers engaged in HIV-related disciplines at varying degrees.
What Will You Cover in This Module?
- Identifying Who Might Best Benefit From Long-Acting ART
- Starting Someone on Long-Acting ART
- Following Someone on Long-Acting ART
- Updates on Long-Acting ART in Understudied Populations
Program Director: Jonathan Schapiro